PRTN3 and rheumatoid arthritis: We previously reported a specific transcriptional signature in peripheral blood cells associated with first-degree relatives negative to anti-cyclic citrullinated peptide antibodies (ACPA) that differentiate relatives positive to ACPA, and a specific transcriptional signature for treatment-naïve newly diagnosed RA patients [4].